Consolidated Statement Of Cash Flows

Perseus Proteomics Inc. - Filing #7585091

Concept 2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-362,085,000 JPY
-273,073,000 JPY
Depreciation
2,081,000 JPY
388,000 JPY
Impairment losses
73,481,000 JPY
9,316,000 JPY
Decrease (increase) in trade receivables
-5,161,000 JPY
3,866,000 JPY
Subtotal
-254,009,000 JPY
-203,259,000 JPY
Income taxes paid
-1,927,000 JPY
-1,927,000 JPY
Decrease (increase) in inventories
-23,000 JPY
-39,000 JPY
Net cash provided by (used in) operating activities
-255,906,000 JPY
-205,161,000 JPY
Other, net
10,137,000 JPY
16,268,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-153,635,000 JPY
-6,409,000 JPY
Net cash provided by (used in) investing activities
-156,007,000 JPY
-6,409,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
JPY
2,623,975,000 JPY
Purchase of treasury shares
-20,000 JPY
JPY
Net cash provided by (used in) financing activities
-20,000 JPY
2,647,548,000 JPY
Effect of exchange rate change on cash and cash equivalents
17,252,000 JPY
951,000 JPY
Net increase (decrease) in cash and cash equivalents
-394,681,000 JPY
2,436,929,000 JPY
Cash and cash equivalents
2,820,171,000 JPY
3,214,852,000 JPY
3,506,229,000 JPY
1,069,300,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.